Sein Kwon

Sunghyun Ahn, Youngwan Jo, Kijung Lee et al.

Video anomaly detection (VAD) is crucial for video analysis and surveillance in computer vision. However, existing VAD models rely on learned normal patterns, which makes them difficult to apply to diverse environments. Consequently, users should retrain models or develop separate AI models for new environments, which requires expertise in machine learning, high-performance hardware, and extensive data collection, limiting the practical usability of VAD. To address these challenges, this study proposes customizable video anomaly detection (C-VAD) technique and the AnyAnomaly model. C-VAD considers user-defined text as an abnormal event and detects frames containing a specified event in a video. We effectively implemented AnyAnomaly using a context-aware visual question answering without fine-tuning the large vision language model. To validate the effectiveness of the proposed model, we constructed C-VAD datasets and demonstrated the superiority of AnyAnomaly. Furthermore, our approach showed competitive results on VAD benchmarks, achieving state-of-the-art performance on UBnormal and UCF-Crime and surpassing other methods in generalization across all datasets. Our code is available online at github.com/SkiddieAhn/Paper-AnyAnomaly.

Sein Kwon, Seulgi Baek, Hyunseo Yang et al.

Database Management Systems (DBMSs) are fundamental for managing large-scale and heterogeneous data, and their performance is critically influenced by configuration parameters. Effective tuning of these parameters is essential for adapting to diverse workloads and maximizing throughput while minimizing latency. Recent research has focused on automated configuration optimization using machine learning; however, existing approaches still exhibit several key limitations. Most tuning frameworks disregard the dependencies among parameters, assuming that each operates independently. This simplification prevents optimizers from leveraging relational effects across parameters, limiting their capacity to capture performancesensitive interactions. Moreover, to reduce the complexity of the high-dimensional search space, prior work often selects only the top few parameters for optimization, overlooking others that contribute meaningfully to performance. Bayesian Optimization (BO), the most common method for automatic tuning, is also constrained by its reliance on surrogate models, which can lead to unstable predictions and inefficient exploration. To overcome these limitations, we propose RelTune, a novel framework that represents parameter dependencies as a Relational Graph and learns GNN-based latent embeddings that encode performancerelevant semantics. RelTune further introduces Hybrid-Score-Guided Bayesian Optimization (HBO), which combines surrogate predictions with an Affinity Score measuring proximity to previously high-performing configurations. Experimental results on multiple DBMSs and workloads demonstrate that RelTune achieves faster convergence and higher optimization efficiency than conventional BO-based methods, achieving state-of-the-art performance across all evaluated scenarios.

Seungyeon Choi, Hwanhee Kim, Chihyun Park et al.

Recent advances in Structure-based Drug Design (SBDD) have leveraged generative models for 3D molecular generation, predominantly evaluating model performance by binding affinity to target proteins. However, practical drug discovery necessitates high binding affinity along with synthetic feasibility and selectivity, critical properties that were largely neglected in previous evaluations. To address this gap, we identify fundamental limitations of conventional diffusion-based generative models in effectively guiding molecule generation toward these diverse pharmacological properties. We propose CByG, a novel framework extending Bayesian Flow Network into a gradient-based conditional generative model that robustly integrates property-specific guidance. Additionally, we introduce a comprehensive evaluation scheme incorporating practical benchmarks for binding affinity, synthetic feasibility, and selectivity, overcoming the limitations of conventional evaluation methods. Extensive experiments demonstrate that our proposed CByG framework significantly outperforms baseline models across multiple essential evaluation criteria, highlighting its effectiveness and practicality for real-world drug discovery applications.